Revolution Medicines, Inc Warrant

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$261,592
$0
Gross Profit
-3,802
-205,749
-188,096
-151,752
EBITDA
-260,912
-237,044
-212,923
-172,835
EBIT
-264,714
-240,760
-216,310
-175,712
Net Income
-247,787
-213,416
-194,569
-156,288
Net Change In Cash
0
0
261,592
0
Free Cash Flow
-229,207
-197,701
-139,512
-133,939
Cash
402,438
333,554
543,064
201,262
Basic Shares
188,145
188,146
167,737
166,843

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$11,580
$35,380
$29,390
Gross Profit
-592,225
-399,664
-217,693
-157,558
EBITDA
-589,022
-456,675
-248,623
-179,747
EBIT
-600,846
-461,685
-258,279
-187,079
Net Income
-600,093
-436,367
-248,705
-187,091
Net Change In Cash
0
11,580
35,380
29,390
Free Cash Flow
-567,744
-358,301
-235,217
-153,708
Cash
543,064
696,148
161,412
108,497
Basic Shares
167,737
113,149
80,626
72,806